pruritus

(redirected from uremic pruritus)
Also found in: Thesaurus, Medical, Encyclopedia.

pru·ri·tus

 (pro͝o-rī′təs)
n.
Severe itching, often of undamaged skin.

[Latin prūrītus, from past participle of prūrīre, to itch; see preus- in Indo-European roots.]

pru·rit′ic (-rĭt′ĭk) adj.

pruritus

(prʊəˈraɪtəs)
n
1. (Pathology) any intense sensation of itching
2. (Pathology) any of various conditions characterized by intense itching
[C17: from Latin: an itching; see prurient]
pruritic adj

pru•ri•tus

(prʊˈraɪ təs)

n.
itching.
[1375–1425; late Middle English < Latin prūrītus an itching, derivative of prūrī(re) to itch]
pru•rit′ic (-ˈrɪt ɪk) adj.
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.pruritus - an intense itching sensation that can have various causes (as by allergies or infection or lymphoma or jaundice etc.)
itchiness, itching, itch - an irritating cutaneous sensation that produces a desire to scratch
pruritus ani - chronic itching of the skin around the anus
pruritus vulvae - persistent itching of the external female genitalia
Translations

pru·ri·tus

n. prurito, comezón, picazón.

pruritus

n prurito, picazón f, comezón f
References in periodicals archive ?
announced that the topline results from its Phase 2 trial of its lead kappa opioid agonist, CR845, for the treatment of moderate to severe uremic pruritus (UP) were statistically significant.
The pathogenesis of uremic pruritus, however, is poorly understood.
The Company is pursuing two conditions for clinical development: uremic pruritus and prurigo nodularis.
8 million and the firm also contrives to utilise the funds for the initiation of pivotal trials in two severe itch conditions: uremic pruritus and prurigo nodularis.
The most common skin changes were xerosis (98%), nail changes (93%), melanocytic nevus (78%), seborrheic keratosis (54%), pigmentation changes (51%), uremic pruritus (49%), tinea pedis (34%), actinic keratosis (23%), skin tags (16%), onychomycosis (17%), lentigo (16%), and cherry angioma (11%).
TRK-820, a highly selective κ (kappa) opioid receptor agonist, was initially launched in March 2009 in Japan as a treatment for hemodialysis-related uremic pruritus.
Company is focused on developing T111 for uremic pruritus and other itching conditions
has demonstrated efficacy in clinical studies of uremic pruritus and is approved in Japan for patients with pruritus undergoing hemodialysis.
Therapeutic effect of topical gamma-linolenic acid on refractory uremic pruritus.
TRK-820 has been developed for treatment of severe uremic pruritus in hemodialysis patients based on the agreement signed by the three parties on March 16, 2005, for joint development and marketing.